If you want to change selection, open document below and click on "Move attachment"
Unknown titlenging potential. In the last five years, both Dr. Doudna and Dr. Charpentier have been recipients of several important prizes in sciences. To what uses has the CRISPR/Cas9 been deployed so far? <span>Earlier this year, a person with hereditary blindness became the first to have a CRISPR/Cas-9-based therapy directly injected into her body. Gene-editing company CRISPR Therapeutics announced in June that two patients with beta thalassemia and one with sickle cell disease would no longer require blood transfusions after thei Summary
status | not read | | reprioritisations | |
---|
last reprioritisation on | | | suggested re-reading day | |
---|
started reading on | | | finished reading on | |
---|
Details